Patents by Inventor Jonathan B. Baell

Jonathan B. Baell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzofuran potassium channel blockers and uses thereof
    Patent number: 8309545
    Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: November 13, 2012
    Assignee: Bionomics Limited
    Inventors: Bernard Luke Flynn, Jonathan B. Baell, Andrew J. Harvey, Jason Hugh Chaplin, Dharam Paul, Jorgen Alvar Mould
  • Chromenone potassium channel blockers and uses thereof
    Patent number: 8217189
    Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: July 10, 2012
    Assignee: Bionomics Limited
    Inventors: Bernard Luke Flynn, Jonathan B. Baell, Andrew J. Harvey, Jason Hugh Chaplin, Dharam Paul, Jorgen Alvar Mould
  • Potassium channel blockers and uses thereof
    Patent number: 8063093
    Abstract: The invention relates to compounds of Formula (1) for use in modulating potassium channel activity in cells.
    Type: Grant
    Filed: March 15, 2006
    Date of Patent: November 22, 2011
    Inventors: Andrew J Harvey, Jonathan B Baell, Heike Wulff
  • NOVEL BENZOFURAN POTASSIUM CHANNEL BLOCKERS AND USES THEREOF
    Publication number: 20100087430
    Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    Type: Application
    Filed: October 4, 2007
    Publication date: April 8, 2010
    Applicant: BIONOMICS LIMITED
    Inventors: Bernard Luke Flynn, Jonathan B. Baell, Andrew J. Harvey, Jason Hugh Chaplin, Dharam Paul, Jorgen Alvar Mould
  • NOVEL CHROMENONE POTASSIUM CHANNEL BLOCKERS AND USES THEREOF
    Publication number: 20090298931
    Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.
    Type: Application
    Filed: October 4, 2007
    Publication date: December 3, 2009
    Applicant: BIONOMICS LIMITED
    Inventors: Bernard Luke Flynn, Jonathan B. Baell, Andrew J. Harvey, Jason Hugh Chaplin, Dharam Paul, Jorgen Alvar Mould
  • Fc receptor modulators and uses thereof
    Patent number: 7553809
    Abstract: This invention relates to a method of inhibiting Fc receptor binding of immunoglobulin including the use of a Fc receptor modulating compound which binds to defined surfaces on a Fc receptor. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.
    Type: Grant
    Filed: June 3, 2004
    Date of Patent: June 30, 2009
    Assignee: Ilexus Pty Limited
    Inventors: Jonathan B. Baell, Thomas P. J. Garrett, P. Mark Hogarth, Barry R. Matthews, Thomas D. McCarthy, Geoffrey A. Pietersz, Maree S. Powell, Ian F. C. McKenzie, Kelly F. Maxwell, Vidana Epa
  • Therapeutic ion channel blocking agents and methods of use thereof
    Patent number: 7507839
    Abstract: Various divalent ligands based on khellinone derivatives are described. These derivatives can be useful in the modulation of potassium channel activity in cells, including among others Kv1.3 channels found in T-cells. The compounds may also be useful in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis.
    Type: Grant
    Filed: March 20, 2003
    Date of Patent: March 24, 2009
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Jonathan B. Baell, Heike Wulff, Andrew J. Harvey, Raymond S. Norton, George K. Chandy
  • Novel Potassium channel Blockers and Uses Thereof
    Publication number: 20080221194
    Abstract: The invention relates to compounds of Formula (1) for use in modulating potassium channel activity in cells.
    Type: Application
    Filed: March 15, 2006
    Publication date: September 11, 2008
    Inventors: Andrew J. Harvey, Jonathan B. Baell, Heike Wulff
  • Fc receptor modulators and uses thereof
    Patent number: 6835753
    Abstract: Methods for inhibiting Fc receptor binding of immunoglobulin in a patient comprising administering pharmaceutical compositions comprising Fc modulating compounds are disclosed.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: December 28, 2004
    Assignee: Ilexus Pty Limited
    Inventors: Jonathan B. Baell, Thomas P. J. Garrett, P. Mark Hogarth, Barry R. Matthews, Thomas D. McCarthy, Geoffrey A. Pietersz
  • Fc receptor modulators and uses thereof
    Publication number: 20020061844
    Abstract: This invention relates to a pharmaceutical composition comprising a Fc receptor modulating compound and a pharmaceutically acceptable carrier. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.
    Type: Application
    Filed: November 26, 2001
    Publication date: May 23, 2002
    Applicant: Ilexus Pty Limited
    Inventors: Jonathan B. Baell, Thomas P.J. Garrett, P. Mark Hogarth, Barry R. Matthews, Thomas D. McCarthy, Geoffrey A. Pietersz
  • Fc receptor modulators and uses thereof
    Patent number: 6355683
    Abstract: This invention relates to a pharmaceutical composition comprising a Fc receptor modulating compound and a pharmaceutically acceptable carrier. The present invention also relates to a method for treating a variety of diseases using a Fc receptor modulating compound.
    Type: Grant
    Filed: September 10, 1999
    Date of Patent: March 12, 2002
    Assignee: Ilexus Pty Limited
    Inventors: Jonathan B. Baell, Thomas P. J. Garrett, P. Mark Hogarth, Barry R. Matthews, Thomas D. McCarthy, Geoffrey A. Pietersz